Navana Pharmaceuticals PLC is a pharmaceutical company that has been operating since 1992. The company has a vision to become one of the leading and trusted names in the pharmaceutical industry. Navana Pharmaceuticals PLC operates in two divisions: the Veterinary Division and the Human Health Division. The Veterinary Division focuses on manufacturing and marketing high-quality medicines and feed supplements for segments such as poultry, dairy, and aqua products. On the other hand, the Human Health Division strictly complies with WHO cGMP guidelines in its manufacturing processes for a wide range of products including tablets, capsules, oral liquids, ampoules, and more. The company has a strong focus on quality and process development, leveraging training and maximum utilization of ICT. It strictly adheres to WHO cGMP guidelines and implements the concept of QMS to ensure the quality of its products. Navana Pharmaceuticals PLC has demonstrated continuous growth in both the domestic and international markets, emphasizing its commitment to quality and innovation. Despite the absence of specific details regarding recent investments or investors, the company's consistent expansion and adherence to international quality standards are notable strengths in positioning itself as an attractive prospect for potential investors in the pharmaceutical sector.
There is no investment information
No recent news or press coverage available for Navana Pharmaceuticals PLC.